...
机译:肺部接种对抗Bordetella Pertussis的优越性免疫的分子和细胞签名
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Natl Inst Publ Hlth &
Environm Ctr Infect Dis Control Bilthoven Netherlands;
Natl Inst Publ Hlth &
Environm Ctr Hlth Protect Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Natl Inst Publ Hlth &
Environm Ctr Infect Dis Control Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Univ Utrecht Dept Infect Dis &
Immunol Utrecht Netherlands;
Leiden Acad Ctr Drug Res Div Drug Delivery Technol Cluster BioTherapeut Leiden Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Natl Inst Publ Hlth &
Environm Ctr Infect Dis Control Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
Natl Inst Publ Hlth &
Environm Ctr Infect Dis Control Bilthoven Netherlands;
Inst Translat Vaccinol Intravacc Bilthoven Netherlands;
机译:对肺部接种疫苗接种肺部疫苗(Vol 11,PG 1009,2018)的分子和细胞签名对抗Bordetella Pertussis
机译:肺部接种对抗Bordetella Pertussis的优越性免疫的分子和细胞签名
机译:来自不同引发小鼠的肺转录组的荟萃分析确定百日咳博德特氏菌挑战后的分子特征以区分免疫反应。
机译:结核分枝杆菌的微囊化ESAT-6的肺部递送优于胃肠外递送方法,可诱导特定的细胞介导的免疫反应
机译:植醇衍生物和小肠粘膜下层的分子和细胞标记在塑造对金黄色葡萄球菌的免疫反应中。
机译:来自不同致敏小鼠的肺转录组的荟萃分析确定百日咳博德特氏菌挑战后的分子特征以区分免疫反应。
机译:错误:对肺部接种时,对Bordetella Pertussis的优越免疫力的分子和细胞签名